Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 009 JPY -0.79% Market Closed
Market Cap: 30.8B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daito Pharmaceutical Co Ltd
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Accounts Payable
ÂĄ11B
CAGR 3-Years
8%
CAGR 5-Years
4%
CAGR 10-Years
10%
Takeda Pharmaceutical Co Ltd
TSE:4502
Accounts Payable
ÂĄ413.3B
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
10%
Daiichi Sankyo Co Ltd
TSE:4568
Accounts Payable
ÂĄ502.8B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
8%
Otsuka Holdings Co Ltd
TSE:4578
Accounts Payable
ÂĄ182.8B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
4%
Chugai Pharmaceutical Co Ltd
TSE:4519
Accounts Payable
ÂĄ88.7B
CAGR 3-Years
-14%
CAGR 5-Years
-3%
CAGR 10-Years
3%
Astellas Pharma Inc
TSE:4503
Accounts Payable
ÂĄ161.2B
CAGR 3-Years
13%
CAGR 5-Years
0%
CAGR 10-Years
-3%
No Stocks Found

Daito Pharmaceutical Co Ltd
Glance View

Market Cap
30.7B JPY
Industry
Pharmaceuticals

Daito Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical products. The company is headquartered in Toyama-Shi, Toyama-Ken and currently employs 846 full-time employees. The company went IPO on 2010-03-24. The pharmaceutical ingredients business is engaged in the manufacture, purchase, sale and entrusted manufacture business of pharmaceutical ingredients used as raw materials for pharmaceutical manufacture and formulation. The formulation business is engaged in the manufacture, purchase, sale and entrusted manufacture business of prescription pharmaceuticals and pharmaceuticals for general-use medicines.

Intrinsic Value
2 429.67 JPY
Undervaluation 17%
Intrinsic Value
Price

See Also

What is Daito Pharmaceutical Co Ltd's Accounts Payable?
Accounts Payable
11B JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Accounts Payable amounts to 11B JPY.

What is Daito Pharmaceutical Co Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
10%

Over the last year, the Accounts Payable growth was 17%. The average annual Accounts Payable growth rates for Daito Pharmaceutical Co Ltd have been 8% over the past three years , 4% over the past five years , and 10% over the past ten years .

Back to Top